{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T22:36:49Z","timestamp":1777329409581,"version":"3.51.4"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2016,4,13]],"date-time":"2016-04-13T00:00:00Z","timestamp":1460505600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Norgine"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Colorectal Dis"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1007\/s00384-016-2585-7","type":"journal-article","created":{"date-parts":[[2016,4,14]],"date-time":"2016-04-14T08:05:44Z","timestamp":1460621144000},"page":"1205-1216","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Libertas: a phase II placebo-controlled study of NRL001 in patients with faecal incontinence showed an unexpected and sustained placebo response"],"prefix":"10.1007","volume":"31","author":[{"given":"L.","family":"Siproudhis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Graf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Emmanuel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. Ng Kwet","family":"Shing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Pediconi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Pilot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Wexner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Scholefield","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,4,13]]},"reference":[{"key":"2585_CR1","first-page":"585","volume":"99","author":"SS Rao","year":"2004","unstructured":"Rao SS (2004) Diagnosis and management of fecal incontinence. Am J Gastroenterol 99:585\u2013604","journal-title":"Am J Gastroenterol"},{"key":"2585_CR2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/BF02237236","volume":"43","author":"TH Rockwood","year":"2000","unstructured":"Rockwood TH, Church JM, Fleshman JW et al (2000) Fecal Incontinence Quality of Life Scale: quality of life instrument for patients with fecal incontinence. Dis Colon Rectum 43:9\u201316","journal-title":"Dis Colon Rectum"},{"key":"2585_CR3","doi-asserted-by":"crossref","first-page":"3276","DOI":"10.3748\/wjg.15.3276","volume":"15","author":"L Bartlett","year":"2009","unstructured":"Bartlett L, Nowak M, Ho YH (2009) Impact of fecal incontinence on quality of life. World J Gastroenterol 15:3276\u20133282","journal-title":"World J Gastroenterol"},{"key":"2585_CR4","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s10151-007-0360-z","volume":"11","author":"L Bartlett","year":"2007","unstructured":"Bartlett L, Nowak M, Ho YH (2007) Reasons for non-disclosure of faecal incontinence: a comparison between two survey methods. Tech Coloproctol 11:251\u2013257","journal-title":"Tech Coloproctol"},{"key":"2585_CR5","first-page":"33","volume":"91","author":"JF Johanson","year":"1996","unstructured":"Johanson JF, Lafferty J (1996) Epidemiology of fecal incontinence: the silent affliction. Am J Gastroenterol 91:33\u201336","journal-title":"Am J Gastroenterol"},{"key":"2585_CR6","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1053\/j.gastro.2009.04.054","volume":"137","author":"WE Whitehead","year":"2009","unstructured":"Whitehead WE, Borrud L, Goode PS et al (2009) Fecal incontinence in US adults: epidemiology and risk factors. Gastroenterology 137:512\u2013517","journal-title":"Gastroenterology"},{"key":"2585_CR7","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1001\/jama.1995.03530070057030","volume":"274","author":"R Nelson","year":"1995","unstructured":"Nelson R, Norton N, Cautley E, Furner S (1995) Community-based prevalence of anal incontinence. JAMA 274:559\u2013561","journal-title":"JAMA"},{"key":"2585_CR8","author":"EH Alsheik","year":"2012","unstructured":"Alsheik EH, Coyne T, Hawes SK et al (2012) Fecal incontinence: prevalence, severity, and quality of life data from an outpatient gastroenterology practice. Gastroenterol Res Pract. doi: 10.1155\/2012\/947694","journal-title":"Gastroenterol Res Pract"},{"key":"2585_CR9","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1111\/ijcp.12018","volume":"66","author":"HW Brown","year":"2012","unstructured":"Brown HW, Wexner SD, Segall MM et al (2012) Accidental bowel leakage in the mature women's health study: prevalence and predictors. Int J Clin Pract 66:1101\u20131108","journal-title":"Int J Clin Pract"},{"key":"2585_CR10","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1136\/gut.50.4.480","volume":"50","author":"S Perry","year":"2002","unstructured":"Perry S, Shaw C, McGrother C et al (2002) Prevalence of faecal incontinence in adults aged 40 years or more living in the community. Gut 50:480\u2013484","journal-title":"Gut"},{"key":"2585_CR11","author":"M Omar","year":"2013","unstructured":"Omar M, Alexander CE (2013) Drug treatment for faecal incontinence in adults. Cochrane Database Syst Rev. doi: 10.1002\/14651858","journal-title":"Cochrane Database Syst Rev"},{"key":"2585_CR12","first-page":"576","volume":"43","author":"DN Kammerer-Doak","year":"1998","unstructured":"Kammerer-Doak DN, Dominguez C, Harner K et al (1998) Surgical repair of fecal incontinence. Correlation of sonographic anal sphincter integrity with subjective cure. J Reprod Med 43:576\u2013580","journal-title":"J Reprod Med"},{"key":"2585_CR13","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2298\/ACI0402073P","volume":"51","author":"J Pfeifer","year":"2004","unstructured":"Pfeifer J (2004) Quality of life after sphincteroplasty. Acta Chir Iugosl 51:73\u201375","journal-title":"Acta Chir Iugosl"},{"key":"2585_CR14","doi-asserted-by":"crossref","first-page":"5267","DOI":"10.3748\/wjg.v16.i42.5267","volume":"16","author":"DF Altomare","year":"2010","unstructured":"Altomare DF, De Fazio M, Giuliani RT et al (2010) Sphincteroplasty for fecal incontinence in the era of sacral nerve modulation. World J Gastroenterol 16:5267\u20135271","journal-title":"World J Gastroenterol"},{"key":"2585_CR15","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1308\/003588410X12628812459652","volume":"92","author":"JM Findlay","year":"2010","unstructured":"Findlay JM, Yeung JM, Robinson R et al (2010) Peripheral neuromodulation via posterior tibial nerve stimulation - a potential treatment for faecal incontinence? Ann R Coll Surg Engl 92:385\u2013390","journal-title":"Ann R Coll Surg Engl"},{"key":"2585_CR16","doi-asserted-by":"crossref","first-page":"9216","DOI":"10.3748\/wjg.v19.i48.9216","volume":"19","author":"JA Koughnett Van","year":"2013","unstructured":"Van Koughnett JA, Wexner SD (2013) Current management of fecal incontinence: choosing amongst treatment options to optimize outcomes. World J Gastroenterol 19:9216\u20139230","journal-title":"World J Gastroenterol"},{"key":"2585_CR17","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1055\/s-0034-1387800","volume":"27","author":"A Barker","year":"2014","unstructured":"Barker A, Hurley J (2014) Novel treatment options for fecal incontinence. Clin Colon Rectal Surg 27:116\u2013120","journal-title":"Clin Colon Rectal Surg"},{"key":"2585_CR18","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1097\/MCG.0000000000000180","volume":"48","author":"SS Rao","year":"2014","unstructured":"Rao SS (2014) Current and emerging treatment options for fecal incontinence. J Clin Gastroenterol 48:752\u2013764","journal-title":"J Clin Gastroenterol"},{"key":"2585_CR19","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1055\/s-2007-977490","volume":"20","author":"T Hull","year":"2007","unstructured":"Hull T (2007) Fecal Incontinence. Clin Colon Rectal Surg 20:118\u2013124","journal-title":"Clin Colon Rectal Surg"},{"key":"2585_CR20","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1046\/j.1365-2036.2001.00995.x","volume":"15","author":"TA Cook","year":"2001","unstructured":"Cook TA, Brading AF, Mortensen NJ (2001) The pharmacology of the internal anal sphincter and new treatments of ano-rectal disorders. Aliment Pharmacol Ther 15:887\u2013898","journal-title":"Aliment Pharmacol Ther"},{"key":"2585_CR21","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1046\/j.1365-2168.1999.01021.x","volume":"86","author":"EA Carapeti","year":"1999","unstructured":"Carapeti EA, Kamm MA, Evans BK et al (1999) Topical phenylephrine increases anal sphincter resting pressure. Br J Surg 86:267\u2013270","journal-title":"Br J Surg"},{"key":"2585_CR22","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1136\/gut.48.3.356","volume":"48","author":"MJ Cheetham","year":"2001","unstructured":"Cheetham MJ, Kamm MA, Phillips RK (2001) Topical phenylephrine increases anal canal resting pressure in patients with faecal incontinence. Gut 48:356\u2013359","journal-title":"Gut"},{"key":"2585_CR23","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1046\/j.1365-2168.2000.01306.x","volume":"87","author":"EA Carapeti","year":"2000","unstructured":"Carapeti EA, Kamm MA, Phillips RK (2000) Randomized controlled trial of topical phenylephrine in the treatment of faecal incontinence. Br J Surg 87:38\u201342","journal-title":"Br J Surg"},{"key":"2585_CR24","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1002\/bjs.4120","volume":"90","author":"OM Jones","year":"2003","unstructured":"Jones OM, Thompson JM, Brading AF et al (2003) L-Erythro-methoxamine is more potent than phenylephrine in effecting contraction of internal anal sphincter in vitro. Br J Surg 90:872\u2013876","journal-title":"Br J Surg"},{"key":"2585_CR25","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/bjs.5171","volume":"92","author":"PJ Nisar","year":"2005","unstructured":"Nisar PJ, Gruss HJ, Bush D et al (2005) Intra-anal and rectal application of L-erythro methoxamine gel increases anal resting pressure in healthy volunteers. Br J Surg 92:1539\u20131545","journal-title":"Br J Surg"},{"key":"2585_CR26","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1002\/bjs.5821","volume":"94","author":"PJ Nisar","year":"2007","unstructured":"Nisar PJ, Gruss HJ, Bush D et al (2007) Intra-anal application of L-erythro methoxamine gel increases anal resting pressure in patients with incontinence. Br J Surg 94:1155\u20131161","journal-title":"Br J Surg"},{"key":"2585_CR27","doi-asserted-by":"crossref","unstructured":"Simpson JA, Bush D, Gruss HJ et al (2014) A randomised, controlled, crossover study to investigate the safety and response of 1R,2S-methoxamine hydrochloride (NRL001) on anal function in healthy volunteers. Color Dis 16(suppl 1):5\u201315","DOI":"10.1111\/codi.12541"},{"key":"2585_CR28","doi-asserted-by":"crossref","unstructured":"Siproudhis L, Jones D, Shing RN et al (2014) Libertas: rationale and study design of a multicentre, Phase II, double-blind, randomised, placebo-controlled investigation to evaluate the efficacy, safety and tolerability of locally applied NRL001 in patients with faecal incontinence. Color Dis 16(suppl 1):59\u201366","DOI":"10.1111\/codi.12546"},{"key":"2585_CR29","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/BF02050307","volume":"36","author":"JMN Jorge","year":"1993","unstructured":"Jorge JMN, Wexner SD (1993) Etiology and management of fecal incontinence. Dis Colon Rectum 36:77\u201397","journal-title":"Dis Colon Rectum"},{"key":"2585_CR30","doi-asserted-by":"crossref","unstructured":"Bell D, Duffin A, Jacobs A et al (2014) A double-blind, placebo-controlled, randomised, parallel group, dose-escalating, repeat dose study in healthy volunteers to evaluate the safety, tolerability, pharmacodynamic effects and pharmacokinetics of the once daily rectal application of NRL001 suppositories for 14 days. Color Dis 16(suppl 1):36\u201350","DOI":"10.1111\/codi.12544"},{"key":"2585_CR31","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1136\/gut.44.1.77","volume":"44","author":"CJ Vaizey","year":"1999","unstructured":"Vaizey CJ, Carapeti E, Cahill JA et al (1999) Prospective comparison of faecal incontinence grading systems. Gut 44:77\u201380","journal-title":"Gut"},{"key":"2585_CR32","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3109\/07853890109002087","volume":"33","author":"R Rabin","year":"2001","unstructured":"Rabin R, de Charro F (2001) EQ-5D: a measure of health status from the EuroQol Group. Ann Med 33:337\u2013343","journal-title":"Ann Med"},{"key":"2585_CR33","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1007\/s11136-011-9903-x","volume":"20","author":"M Herdman","year":"2011","unstructured":"Herdman M, Gudex C, Lloyd A et al (2011) Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res 20:1727\u20131736","journal-title":"Qual Life Res"},{"key":"2585_CR34","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/BF02234823","volume":"44","author":"J Rothbarth","year":"2001","unstructured":"Rothbarth J, Bemelman WA, Meijerink WJ et al (2001) What is the impact of fecal incontinence on quality of life? Dis Colon Rectum 44:67\u201371","journal-title":"Dis Colon Rectum"},{"key":"2585_CR35","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1007\/s10350-006-0514-5","volume":"49","author":"M Minguez","year":"2006","unstructured":"Minguez M, Garrigues V, Soria MJ et al (2006) Adaptation to Spanish language and validation of the fecal incontinence quality of life scale. Dis Colon Rectum 49:490\u2013499","journal-title":"Dis Colon Rectum"},{"key":"2585_CR36","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/S0399-8320(04)95012-9","volume":"28","author":"E Rullier","year":"2004","unstructured":"Rullier E, Zerbib F, Marrel A et al (2004) Validation of the French version of the Fecal Incontinence Quality-of-Life (FIQL) scale. Gastroenterol Clin Biol 28:562\u2013568","journal-title":"Gastroenterol Clin Biol"},{"key":"2585_CR37","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00384-009-0830-z","volume":"25","author":"M Zutshi","year":"2010","unstructured":"Zutshi M, Salcedo L, Hammel J et al (2010) Anal physiology testing in fecal incontinence: is it of any value? Int J Color Dis 25:277\u2013282","journal-title":"Int J Color Dis"},{"key":"2585_CR38","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s00384-006-0101-1","volume":"21","author":"C Evans","year":"2006","unstructured":"Evans C, Davis K, Kumar D (2006) Overlapping anal sphincter repair and anterior levatorplasty: effect of patient's age and duration of follow-up. Int J Color Dis 21:795\u2013801","journal-title":"Int J Color Dis"},{"key":"2585_CR39","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1046\/j.1365-2168.2000.01568.x","volume":"87","author":"A Osterberg","year":"2000","unstructured":"Osterberg A, Edebol Eeg-Olofsson K, Graf W (2000) Results of surgical treatment for faecal incontinence. Br J Surg 87:1546\u20131552","journal-title":"Br J Surg"},{"key":"2585_CR40","doi-asserted-by":"crossref","unstructured":"Bell D, Pediconi C, Jacobs A (2014) Randomised clinical trial: study of escalating doses of NRL001 given in rectal suppositories of different weights. Color Dis 16(suppl 1):16\u201326","DOI":"10.1111\/codi.12542"},{"key":"2585_CR41","doi-asserted-by":"crossref","unstructured":"Bell D, Duffin A, Gruss HJ et al (2014) A randomised, controlled, crossover study to investigate the pharmacodynamics, pharmacokinetics and safety of 1R,2S-methoxamine hydrochloride (NRL001) in healthy elderly subjects. Color Dis 16(suppl 1):27\u201335","DOI":"10.1111\/codi.12543"},{"key":"2585_CR42","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1213\/ANE.0b013e3182120ca5","volume":"113","author":"RH Thiele","year":"2011","unstructured":"Thiele RH, Nemergut EC, Lynch C 3rd (2011) The Clinical Implications of Isolated Alpha1 Adrenergic Stimulation. Anesth Analg 113:297\u2013304","journal-title":"Anesth Analg"},{"key":"2585_CR43","doi-asserted-by":"crossref","unstructured":"Gruss HJ, Pediconi C, Jacobs A (2014) Meta-analysis for cardiovascular effects of NRL001 after rectal application in healthy volunteers. Color Dis 16(suppl 1):51\u201358","DOI":"10.1111\/codi.12545"},{"key":"2585_CR44","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/S0140-6736(10)62297-0","volume":"377","author":"W Graf","year":"2011","unstructured":"Graf W, Mellgren A, Matzel KE et al (2011) Efficacy of dextranomer in stabilised hyaluronic acid for treatment of faecal incontinence: a randomised, sham-controlled trial. Lancet 377:997\u20131003","journal-title":"Lancet"},{"key":"2585_CR45","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/DCR.0b013e318200f866","volume":"54","author":"MT Wong","year":"2011","unstructured":"Wong MT, Meurette G, Rodat F et al (2011) Outcome and management of patients in whom sacral nerve stimulation for fecal incontinence failed. Dis Colon Rectum 54:425\u2013432","journal-title":"Dis Colon Rectum"},{"key":"2585_CR46","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/codi.12403","volume":"16","author":"M Frascio","year":"2014","unstructured":"Frascio M, Mandolfino F, Imperatore M et al (2014) The SECCA procedure for faecal incontinence: a review. Color Dis 16:167\u2013172","journal-title":"Color Dis"},{"key":"2585_CR47","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.gastro.2003.09.039","volume":"125","author":"C Norton","year":"2003","unstructured":"Norton C, Chelvanayagam S, Wilson-Barnett J et al (2003) Randomized controlled trial of biofeedback for fecal incontinence. Gastroenterology 125:1320\u20131329","journal-title":"Gastroenterology"},{"key":"2585_CR48","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1586\/ern.10.8","volume":"10","author":"JG Speciali","year":"2010","unstructured":"Speciali JG, Peres M, Bigal ME (2010) Migraine treatment and placebo effect. Expert Rev Neurother 10:413\u2013419","journal-title":"Expert Rev Neurother"},{"key":"2585_CR49","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1111\/j.1365-2036.2007.03293.x","volume":"25","author":"L Siproudhis","year":"2007","unstructured":"Siproudhis L, Morcet J, Lain\u00e9 F (2007) Elastomer implants in faecal incontinence: a blind, randomized placebo-controlled study. Aliment Pharmacol Ther 25:1125\u20131132","journal-title":"Aliment Pharmacol Ther"},{"key":"2585_CR50","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1097\/01.sla.0000186281.09475.db","volume":"242","author":"AM Leroi","year":"2005","unstructured":"Leroi AM, Parc Y, Lehur PA et al (2005) Efficacy of sacral nerve stimulation for fecal incontinence: results of a multicenter double-blind crossover study. Ann Surg 242:662\u2013669","journal-title":"Ann Surg"},{"key":"2585_CR51","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1038\/ajg.2012.330","volume":"107","author":"AM Leroi","year":"2012","unstructured":"Leroi AM, Siproudhis L, Etienney I et al (2012) Transcutaneous electrical tibial nerve stimulation in the treatment of fecal incontinence: a randomized trial (CONSORT 1a). Am J Gastroenterol 107:1888\u20131896","journal-title":"Am J Gastroenterol"},{"key":"2585_CR52","volume":"7","author":"C Norton","year":"2012","unstructured":"Norton C, Cody JD (2012) Biofeedback and\/or sphincter exercises for the treatment of faecal incontinence in adults. Cochrane Database Syst Rev 7, CD002111","journal-title":"Cochrane Database Syst Rev"},{"key":"2585_CR53","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1037\/0021-843X.98.1.89","volume":"98","author":"TF Heatherton","year":"1989","unstructured":"Heatherton TF, Polivy J, Herman CP (1989) Restraint and internal responsiveness: effects of placebo manipulations of hunger state on eating. J Abnorm Psychol 98:89\u201392","journal-title":"J Abnorm Psychol"},{"key":"2585_CR54","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/PSY.0b013e3182915ee7","volume":"75","author":"B Horing","year":"2013","unstructured":"Horing B, Weimer K, Schrade D et al (2013) Reduction of motion sickness with an enhanced placebo instruction: an experimental study with healthy participants. Psychosom Med 75:497\u2013504","journal-title":"Psychosom Med"},{"key":"2585_CR55","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.pain.2005.03.014","volume":"115","author":"L Vase","year":"2005","unstructured":"Vase L, Robinson ME, Verne GN et al (2005) Increased placebo analgesia over time in irritable bowel syndrome (IBS) patients is associated with desire and expectation but not endogenous opioid mechanisms. Pain 115:338\u2013347","journal-title":"Pain"},{"key":"2585_CR56","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jpsychores.2005.12.004","volume":"61","author":"MA Flaten","year":"2006","unstructured":"Flaten MA, Aslaksen PM, Finset A et al (2006) Cognitive and emotional factors in placebo analgesia. J Psychosom Res 61:81\u201389","journal-title":"J Psychosom Res"},{"key":"2585_CR57","doi-asserted-by":"crossref","first-page":"91S","DOI":"10.1016\/S0002-9343(99)00086-8","volume":"107","author":"RC Spiller","year":"1999","unstructured":"Spiller RC (1999) Problems and challenges in the design of irritable bowel syndrome clinical trials: experience from published trials. Am J Med 107:91S\u201397S","journal-title":"Am J Med"},{"key":"2585_CR58","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S1542-3565(04)00626-3","volume":"3","author":"M Pitz","year":"2005","unstructured":"Pitz M, Cheang M, Bernstein CN (2005) Defining the predictors of the placebo response in irritable bowel syndrome. Clin Gastroenterol Hepatol 3:237\u2013247","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["International Journal of Colorectal Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-016-2585-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00384-016-2585-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-016-2585-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T19:16:20Z","timestamp":1553627780000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00384-016-2585-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,13]]},"references-count":58,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["2585"],"URL":"https:\/\/doi.org\/10.1007\/s00384-016-2585-7","relation":{},"ISSN":["0179-1958","1432-1262"],"issn-type":[{"value":"0179-1958","type":"print"},{"value":"1432-1262","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,13]]}}}